A recently published study by FMI expects the global common warts market to augment at a 3.6% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 1,100 Million is expected for the market. The increase in pharmaceutical R&D activity for efficient and focused treatment of common warts.
North America Common Warts Market is expected to grow at a CAGR of 3.5% in the assessment period 2023-2033. The Asia Pacific is expected to grow at a CAGR.